When was NeuroCONCISE founded?

NeuroCONCISE was founded in 2016.

Where is NeuroCONCISE located?

NeuroCONCISE is headquartered in Londonderry, United Kingdom.

Which legal entities is NeuroCONCISE associated with?

NeuroCONCISE is associated with NEUROCONCISE LTD.

How many employees does NeuroCONCISE have?

As of Mar 31, 2026, the latest employee count at NeuroCONCISE is 6.

Is NeuroCONCISE a funded company?

NeuroCONCISE is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does NeuroCONCISE rank among its competitors?

NeuroCONCISE ranks 177th amongst 148 active competitors, of which 40 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was PanGenomic, which secured $1.43M in Dec, 2025.

Who are the top competitors of NeuroCONCISE?

NeuroCONCISE's top competitors include Irisbond, Brain.Space and NeuroXess. Among them, PanGenomic secured the most recent funding round in December, 2025.

NeuroCONCISE - 2026 Company Profile, Funding, Competitors & Financials

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NEUROCONCISE LTD CIN: NI642461 , United Kingdom, Active	Nov 29, 2016	-	4 (As on Dec 31, 2024)

NeuroCONCISE's employee count trend

NeuroCONCISE has 6 employees as of Mar 26. Here is NeuroCONCISE's employee count trend over the years:

Uncover NeuroCONCISE's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroCONCISE include Irisbond, Brain.Space and NeuroXess. Here is the list of Top 10 competitors of NeuroCONCISE, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Irisbond 2013, San Sebastian (Spain), Series A	Developer of eye tracking solution to control a computer for disabled individuals	$7.03M	BBVA Momentum, Spri & 3 others	55/100
2nd	Brain.Space 2018, Tel Aviv (Israel), Series A	Digital brain activity analysis device for providers	$19.5M	Mangrove Capital Partners, Toyota Ventures ... & 2 others	55/100
3rd	NeuroXess 1970, Huangpu (China), Seed	Provider of decision-support diagnostic solutions for healthcare organizations	$13.9M	Sequoia Capital, Sunda & 11 others	51/100
4th	machineMD 2019, Bern (Switzerland), Seed	Developer of a device for the diagnosis of brain disease	$4.77M	Guido Fluri Stiftung, Swiss ICT Investor Club ... & 3 others	49/100
5th	Rhaeos 2018, Evanston (United States), Series A	Developer of a noninvasive device to monitor CSF and manage hydrocephalus	$12.8M	Gener8tor, Steele Foundation for Hope & 14 others	45/100
6th	Manus Neuro 2008, Motherwell (United Kingdom), Series A	Provider of devices for recognizing biomarkers of neuromotor impairments	$6.84M	Par Equity, Northstar Ventures & 12 others	45/100
7th	PanGenomic 2020, Vancouver (Canada), Public	Online teleconsultation platform for the patients and healthcare providers	-	GetFresh Ventures	44/100
8th	Advanced Brain Monitoring 1997, San Diego (United States), Early Stage	Provider of neuro-diagnostics devices for researchers and clinical trials	$1.24M	National Heart Lung and Blood Institute, NIDA ... & 2 others	44/100
9th	BrainSpace 2021, Bothell (United States), Seed	Wearable ventricular drain monitoring solutions for physicians	$280K	Seattle Angel Conference, K1 Investment Management	42/100
10th	RetiSpec 2015, Tel Aviv (Israel), Series A	Non-invasive eye scanner for early detection of Alzheimer’s Disease.	$17M	iGan Partners, Lilly & 9 others	42/100
177th	NeuroCONCISE 2016, Londonderry (United Kingdom), Funding Raised	Provider of wearable neurotechnology device for brainwave measurement and analysis	-	Techstart Ventures	17/100